Caraway Therapeutics Receives Third Research Grant from The Michael J. Fox Foundation to Continue Advancement of TRPML1 Agonists for GBA-Parkinson’s Disease
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Caraway Therapeutics today announced that the Company has been awarded a third research…
Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion